Compare Kaneka Corp. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 6.28% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.17% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 6.28% of over the last 5 years
3
Positive results in Mar 26
4
With ROCE of 5.11%, it has a very attractive valuation with a 0.82 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
JPY 361,620 Million (Mid Cap)
12.00
NA
0.00%
0.33
7.47%
0.72
Revenue and Profits:
Net Sales:
213,360 Million
(Quarterly Results - Mar 2026)
Net Profit:
13,022 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.61%
0%
19.61%
6 Months
20.48%
0%
20.48%
1 Year
33.75%
0%
33.75%
2 Years
69.18%
0%
69.18%
3 Years
48.41%
0%
48.41%
4 Years
67.99%
0%
67.99%
5 Years
33.9%
0%
33.9%
Kaneka Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.06%
EBIT Growth (5y)
6.28%
EBIT to Interest (avg)
17.30
Debt to EBITDA (avg)
1.68
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.19
Tax Ratio
27.21%
Dividend Payout Ratio
31.92%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
6.51%
ROE (avg)
6.17%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.76
EV to EBIT
16.08
EV to EBITDA
6.65
EV to Capital Employed
0.82
EV to Sales
0.66
PEG Ratio
5.40
Dividend Yield
NA
ROCE (Latest)
5.11%
ROE (Latest)
6.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2013
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
213,360.00
200,850.00
6.23%
Operating Profit (PBDIT) excl Other Income
23,065.00
19,211.00
20.06%
Interest
1,067.00
1,000.00
6.70%
Exceptional Items
-5,338.00
-200.00
-2,569.00%
Consolidate Net Profit
13,022.00
7,751.00
68.00%
Operating Profit Margin (Excl OI)
50.10%
36.00%
1.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.23% vs 1.06% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 68.00% vs 7.47% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
811,638.00
807,200.00
0.55%
Operating Profit (PBDIT) excl Other Income
79,567.00
83,697.00
-4.93%
Interest
4,090.00
4,026.00
1.59%
Exceptional Items
-6,124.00
-3,076.00
-99.09%
Consolidate Net Profit
32,581.00
26,805.00
21.55%
Operating Profit Margin (Excl OI)
39.00%
48.40%
-0.94%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 0.55% vs 5.89% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 21.55% vs 8.19% in Mar 2025
About Kaneka Corp. 
Kaneka Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






